Boutique economic consulting firm helping businesses understand and analyze healthcare, tax, and fiscal policy
Washington, DC
Joined October 2013
- Tweets275
- Following244
- Followers67
- Likes51
Pinned Tweet
See how MGA helps clients understand, respond to, and influence public policy!
getmga.com/wp-content/upload…
Matrix Global Advisors (MGA) retweeted
.@MGA_Health Releases New White Paper on Medicare Price Negotiations and Drug Competition:
“If a brand drug’s price could be set by the government prior to generic entry, generic drugmakers’ incentives to undertake the risk and expense associated with bringing a generic to market will be reduced. The risk and cost associated with bringing biosimilars to market is even greater than for small-molecule drugs given the complexity of developing these products, and increased uncertainty will also discourage biosimilar manufacturers.”
Read More from Matrix Global Advisors: getmga.com/mga-releases-new-…
It's been 10 years since the first US biosimilar approval. The second decade of this market is underway, it's important for policymakers to address remaining barriers to a competitive marketplace for biologic drugs. Check out our new paper! getmga.com/wp-content/upload…
Matrix Global Advisors (MGA) retweeted
A new blog by former policy director and chief economist for the U.S. House Committee on Ways and Means Alex Brill, warning against government intervention in the private health market. getmga.com/congress-on-the-b…
Matrix Global Advisors (MGA) retweeted
Congress is considering misguided proposals targeting the market-based role of pharmacy benefit companies in the health care system. Learn more: pcmanet.org/pcma-blog/stop-t…
Read MGA's new post about the economics of delinking and why this is not good for patients.
getmga.com/economics-of-deli…
Tomorrow, the Senate Judiciary Committee will hold a hearing about competition in the prescription drug market. Will Congress finally do something? We wrote about it on our blog, and we'll be watching tomorrow's hearing closely.
getmga.com/will-congress-fin…
Matrix Global Advisors (MGA) retweeted
@AlexBrill_DC , founder and CEO of @MGA_Health and former policy director and chief economist for the House Committee on Ways and Means, examines how the insulin market has changed – for the betterment of patients – over the years, underscoring how competition from the free market is working to deliver savings for patients: pcmanet.org/pcma-blog/alex-b…
Matrix Global Advisors (MGA) retweeted
A new blog by @AlexBrill_DC of @MGA_Health Biden Budget Proposes a Step Toward Biologic Drug Competition getmga.com/biden-budget-prop…
Matrix Global Advisors (MGA) retweeted
New report: Before placing limits on the rebates that lower drug prices, Congress should consider the potential harm to patients, taxpayers and the healthcare system. affordableprescriptiondrugs.…
Matrix Global Advisors (MGA) retweeted
Read @MGA_Health’s latest report for more on how despite Big Pharma’s claims, PBM-negotiated rebates LOWER prescription drugs prices, not raise them. affordableprescriptiondrugs.…
Matrix Global Advisors (MGA) retweeted
“Look at policies that address the root of the problem: drug companies’ monopolistic pricing power,” says CAPD’s Maura Keefe on @MGA_Health’s latest report. Read more: affordableprescriptiondrugs.…
Matrix Global Advisors (MGA) retweeted
@MGA_Health’s @AlexBrill_DC in a new research report for @RxDrugCoalition: “If Congress wants to lower drug prices, the data shows that targeting rebates will not be effective.” Read the full report: affordableprescriptiondrugs.…
Matrix Global Advisors (MGA) retweeted
Despite drug companies’ claims that rebates drive up drug prices, a new report from @MGA_Health finds that the prescription drugs that have increased most in price DO NOT have rebates. Learn how Big Pharma tries to shift blame for the high drug prices: affordableprescriptiondrugs.…
Matrix Global Advisors (MGA) retweeted
.@MGA_Health’s latest report: combatting high and pricing prescription drug prices will require Congress to focus on policies that promote drug competition. More on the findings here: affordableprescriptiondrugs.…
Matrix Global Advisors (MGA) retweeted
NEW: For lawmakers looking to lower drug costs for patients, @MGA_Health’s new report is a must-read. The findings are clear: Congress should to focus on policies that promote competition to lower drug prices, not limit pharmacy benefits affordableprescriptiondrugs.…
Matrix Global Advisors (MGA) retweeted
To combat high and rising prescription drug prices, Congress should focus on policies that promote drug competition. More here in new research from @MGA_Health: affordableprescriptiondrugs.…
Matrix Global Advisors (MGA) retweeted
.@MGA_Health’s latest research finds that among drugs without rebates, price increases ranged over 400% & average price hikes were a whopping 93%. The top drugs with rebates saw much lower price increases: 44% on average. Learn more: affordableprescriptiondrugs.…
Matrix Global Advisors (MGA) retweeted
NEW research from @MGA_Health finds 9 of the 10 prescription drugs that have increased most in price since 2018 DO NOT have rebates. Learn more about their findings: affordableprescriptiondrugs.…